Skip to main content
Category

Advocacy

AdvocacyFunding

EGFR Resisters and LCRF Research Partnership

*November 2021* RESEARCH=SURVIVAL! As you may know, we have increased our goal to $225K to keep fundraising for additional research projects that we will fund through our collaboration with LCRF in 2022. These research projects will be dedicated to EGFR+ lung cancer and hopefully lead to discoveries that will provide…
laurabbook@gmail.com
November 12, 2021
Advocacy

Words Matter

*September 2021* EGFR Resisters co-founder Jill Feldman presented how stigmatizing words can affect patients and their families at WCLC 2021. Watch the video presentation here.
laurabbook@gmail.com
November 11, 2021